Please use this identifier to cite or link to this item: https://hdl.handle.net/2440/7104
Citations
Scopus Web of Science® Altmetric
?
?
Full metadata record
DC FieldValueLanguage
dc.contributor.authorLerner, Terry J.en
dc.contributor.authorBoustany, Rose-Mary N.en
dc.contributor.authorAnderson, John W.en
dc.contributor.authorD'Arigo, Kenneth L.en
dc.contributor.authorSchlumpf, Karenen
dc.contributor.authorBuckler, Alan J.en
dc.contributor.authorGusella, James F.en
dc.contributor.authorHaines, Jonathan L.en
dc.date.issued1995en
dc.identifier.citationCell, 1995; 82:949-957en
dc.identifier.issn0092-8674en
dc.identifier.urihttp://hdl.handle.net/2440/7104-
dc.descriptionCopyright © 2009 Elsevier B.V. All rights reserved.en
dc.description.abstractBatten disease (also known as juvenile neuronal ceroid lipofuscinosis) is a recessively inherited neurodegenerative disorder of childhood characterized by progressiveloss of vision, seizures, and psychomotor disturbances. The Batten disease gene, CLN3, maps to chromosome 16p12.1. The so-called 56 chromosome haplotype defined by alleles at the D16S299 and D16S298 loci is shared by 73% of Batten disease chromosomes. Exon amplification of a cosmid containing D16S298 has yielded a candidate gene that is disrupted by a 1 kb genomic deletion in all patients carrying the 56 chromosome. Two separate deletions and a point mutation altering a splice site in three unrelated families have confirmed the candidate as the CLN3 gene. The disease gene encodes a novel 438 amino acid protein of unknown function.en
dc.description.urihttp://www.sciencedirect.com/science/journal/00928674en
dc.language.isoenen
dc.publisherMIT Pressen
dc.titleIsolation of a novel gene underlying Batten disease, CLN3en
dc.typeJournal articleen
dc.identifier.doi10.1016/0092-8674(95)90274-0en
Appears in Collections:Paediatrics publications

Files in This Item:
There are no files associated with this item.


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.